Although AS and/or SRP did not affect the efficacy of CTX chemotherapy (compared with CTX-alone group, the tumor mass in CTX + AS, CTX + SRP, and CTX + AS + SRP groups was not changed significantly) (Figure 5A), they could alleviate the reduction of WBCs (Table 1) and BMNCs (Figure 5B) caused by CTX chemotherapy. Here, UCN2 is linked to neoplasm.